About Bio-AI Health
Bio-AI Health is a company based in Goffstown (United States) founded in 2020 by Alan Jerusalmi and Thomas Colarusso. Bio-AI Health has raised $3.5 million across 2 funding rounds. Bio-AI Health offers products and services including AI Biomarker Services, PredictX Platform, and Data Sourcing Services. Bio-AI Health operates in a competitive market with competitors including PathAI, Viz.ai, Deepcell, Deciphex and Aignostics, among others.
- Headquarter Goffstown, United States
- Founders Alan Jerusalmi, Thomas Colarusso
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bioai Health Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.5 M (USD)
in 2 rounds
-
Latest Funding Round
$500 K (USD), Seed
Apr 05, 2024
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bio-AI Health
Bio-AI Health offers a comprehensive portfolio of products and services, including AI Biomarker Services, PredictX Platform, and Data Sourcing Services.
Identifies genetic mutations in images for rapid patient screening.
Enables causal AI for disease biology and drug target identification.
Provides access to biospecimen and clinical data for research needs.
People of Bio-AI Health
Unlock access to complete
Leadership Team
3 people
Sales and Marketing
1 people
Lead Team
1 people
Translational Team
1 people
Unlock access to complete
Funding Insights of Bio-AI Health
Bio-AI Health has successfully raised a total of $3.5M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $500 thousand completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Bio-AI Health
Investment portfolio details for Bio-AI Health
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Bio-AI Health
Detailed financials for Bio-AI Health
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bio-Ai Health Comparisons
Peer comparison for Bio-AI Health
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bio-AI Health
Bio-AI Health operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PathAI, Viz.ai, Deepcell, Deciphex and Aignostics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases
|
|
| Locked | Locked | Locked |
AI and cloud-powered software for stroke care coordination is developed.
|
|
| Locked | Locked | Locked |
AI-powered single cell classification and isolation technology for clinical research
|
|
| Locked | Locked | Locked |
Digital pathology software is developed for clinical and veterinary productivity.
|
|
| Locked | Locked | Locked |
AI-based pathology diagnostic software is provided for medical analysis.
|
|
| Locked | Locked | Locked |
AI-based tools for pathological image analysis are provided to labs.
|
Detailed competitors of Bio-AI Health
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bio-Ai Health
Complete news archive for Bio-AI Health
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bio-AI Health
Bio-AI Health was founded in 2020 and raised its 1st funding round 2 years after it was founded.
Bio-AI Health is headquartered in Goffstown, United States. It is registered at Goffstown, New Hampshire, United States.
Thomas Colarusso is the current CEO of Bio-AI Health. They have also founded this company.
Bio-AI Health is a funded company, having raised a total of $3.5M across 2 funding rounds to date.
Bio-AI Health was founded in 2020 in Goffstown, United States, within the healthcare and AI sector. Software is developed by the company to support precision medicine and patient profiling. Features for pathology analysis and multi-omic data processing are included in the diagnosis tool. Assistance is offered to healthcare professionals through these integrated capabilities.
Bio-AI Health's top competitors include Aignostics, Deciphex and Pictor Labs.
Bio-AI Health offers AI Biomarker Services, PredictX Platform, and Data Sourcing Services.